Genetic alterations such as BRAF and TERT mutations can also affect the survival rate of thyroid cancer patients [16] Ferroptosis, a recently discovered type of programmed cell death, appears to play a critical role in carcinogenesis and cancer therapy efficacy, according to mounting data [17,18]. The gene discussed is BRAF; the disease is thyroid gland carcinoma.